The discovery of a novel approach to promote cardiomyocyte proliferation offers new hope for the treatment of ischemic heart failure.

A discovery in cardiac regeneration offers ew hope for the treatment of ischemic heart failure. Published in npj Regenerative ...

Researchers report a discovery in cardiac regeneration that offers new hope for the treatment of ischemic heart failure.

Many cancer patients go on to develop heart failure -- because of the cancer ... Breakthrough Cardiac Regeneration Research Offers Hope for the Treatment of Ischemic Heart Failure Mar. 7 ...

Researchers in the Michael E. DeBakey Department of Surgery at Baylor College of Medicine, the QIMR Berghofer Medical Research Institute in Brisbane, Australia, and collaborating institutions report a ...

Researchers at UT Southwestern Medical Center found that tenecteplase, a newer drug, is just as safe and effective as ...

One of the most common symptoms of ischemic heart disease is ... but sometimes heart failure can also be reversed with treatments such as medication or surgery.

The study, published March 12 in JAMA Network Open, compared the newly approved tenecteplase in a single quick injection to alteplase, the stroke treatment that has been used for decades and requires ...

Genentech’s label expansion for TNKase consolidates its market position for pharmacological stroke treatments.

Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...

A global team of researchers has reported a groundbreaking discovery in cardiac regeneration that offers new hope for the ...